Sitagliptin Pinewood 25 mg film-coated tablets Írland - enska - HPRA (Health Products Regulatory Authority)

sitagliptin pinewood 25 mg film-coated tablets

pinewood laboratories ltd - sitagliptin hydrochloride - film-coated tablet - sitagliptin

Sitagliptin Pinewood 50 mg film-coated tablets Írland - enska - HPRA (Health Products Regulatory Authority)

sitagliptin pinewood 50 mg film-coated tablets

pinewood laboratories ltd - sitagliptin hydrochloride - film-coated tablet - sitagliptin

Sitagliptin/Metformin hydrochloride Rowex 50/1000 mg Film-coated tablets Írland - enska - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin hydrochloride rowex 50/1000 mg film-coated tablets

rowex ltd - sitagliptin hydrochloride; metformin hydrochloride - film-coated tablet - 50/1000 milligram(s) - metformin and sitagliptin

Sitagliptin/Metformin hydrochloride Rowex 50/850 mg Film-coated tablets Írland - enska - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin hydrochloride rowex 50/850 mg film-coated tablets

rowex ltd - sitagliptin hydrochloride; metformin hydrochloride - film-coated tablet - 50/850 milligram(s) - metformin and sitagliptin

Sitagliptin/Metformin Hydrochloride Pinewood 50 mg/1000 mg film-coated tablets Írland - enska - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin hydrochloride pinewood 50 mg/1000 mg film-coated tablets

pinewood laboratories ltd - sitagliptin hydrochloride; metformin hydrochloride - film-coated tablet - metformin and sitagliptin

Sitagliptin/Metformin Hydrochloride Pinewood 50 mg/850 mg film-coated tablets Írland - enska - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin hydrochloride pinewood 50 mg/850 mg film-coated tablets

pinewood laboratories ltd - sitagliptin hydrochloride; metformin hydrochloride - film-coated tablet - metformin and sitagliptin

JANORIX sitagliptin 50 mg film-coated tablet bottle Ástralía - enska - Department of Health (Therapeutic Goods Administration)

janorix sitagliptin 50 mg film-coated tablet bottle

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 54.5 mg (equivalent: sitagliptin, qty 50 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; povidone; sodium stearylfumarate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - janorix is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

JANORIX sitagliptin 50 mg film-coated tablet blister pack Ástralía - enska - Department of Health (Therapeutic Goods Administration)

janorix sitagliptin 50 mg film-coated tablet blister pack

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 54.5 mg (equivalent: sitagliptin, qty 50 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; magnesium stearate; povidone; microcrystalline cellulose; sodium stearylfumarate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - janorix is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

JANORIX sitagliptin 25 mg film-coated tablet bottle Ástralía - enska - Department of Health (Therapeutic Goods Administration)

janorix sitagliptin 25 mg film-coated tablet bottle

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 27.25 mg (equivalent: sitagliptin, qty 25 mg) - tablet, film coated - excipient ingredients: magnesium stearate; sodium stearylfumarate; croscarmellose sodium; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; povidone; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - janorix is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

JANORIX sitagliptin 25 mg film-coated tablet blister pack Ástralía - enska - Department of Health (Therapeutic Goods Administration)

janorix sitagliptin 25 mg film-coated tablet blister pack

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 27.25 mg (equivalent: sitagliptin, qty 25 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; croscarmellose sodium; magnesium stearate; sodium stearylfumarate; povidone; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - janorix is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].